Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-143040

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 27, 2016
Accepted (ET)
Sep 28, 2016 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Sep 27, 2016S627$54.15D109,659D
Common stockF2,F3Sep 27, 2016S625$54.15D109,693ISee footnote
Common stockF4Sep 28, 2016S627$54.00D109,032D
Common stockF4,F3Sep 28, 2016S625$54.00D109,068ISee footnote
Common stockF5holding———12,500ISee footnote
Common stockF6holding———12,500ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses